Mikhail Blagosklonny and Work Towards a Better Life

Medicine and science have made fantastic progress over the last hundred years. The advancements help people on a daily basis to combat illness and live longer. One of the diseases science is still trying to cure cancer. It is a tricky one because it is very unpredictable. At this point, there are success stories, and then there are those not so lucky. However, scientists and researchers don’t plan on giving up till they have achieved their goal – to cure the disease completely in all its various forms. One such researcher is Mikhail Blagosklonny whose name is not very well-known to many people.

With a background in oncology, Mikhail Blagosklonny primarily studies cancer and how it relates to age. Oder people are in the higher risk group even though there are different reasons people encounter this disease in life and not all of them are yet explained. However, there is an idea that a possibility of preventing cancer is more likely achievable than curing it. Advanced stages of the disease cannot be cured so people can only manage it and try to raise their quality of life as much as possible. Researchers also want to find a less invasive cancer therapy and read full article.

The current methods – chemotherapy and radiation have severed side-effects. People experience nausea, weakness and other unpleasant things after they spend time receiving treatment. Many are not able to attend therapy sessions alone since they are unable to get back home afterward. Creating a treatment method that would take away the side-effects or at least decrease their intensity would be a huge step towards the big goal. Mikhail Blagosklonny believes that aging happens because human cells get damaged over time, and at some point, they lose their ability to carry out repairs. However, using rapamycin and other rapalogs might extend human life, increasing the quality of life in the process.

Improving the immunity also helps and this is what a rapamycin alternative – Evirolimus achieves. Rapamycin itself is used mainly for patients after transplantations to ensure that their body will accept the new addition. It is also employed in cases people suffer from age-related illnesses. There is an idea that extending the human life would allow the cells to change and cancer cells would not be able to form or disguise themselves in the body. However, any treatment would have to be administered before the diagnosis of cancer since otherwise, it would not be effective and what Dr. Mikhail knows.

Mikhail Blagosklonny is passionate about this field is study. St. Petersburg was where his interest for oncology was born after studies and receiving his M.D. and later his Ph.D. in medicine. Mikhail chose cardiology as a field of specialization and has not left it since but acquired more knowledge and experience working in the States. He decided to dedicate his world and life to research and publication. One of the most well-known journals he works for is Oncotarget and Mikhail’s lacrosse camp.

Blagosklonny believes that offering scientists an opportunity to publish their research is a significant step towards the goal. It is a peer- reviewed journal and offers its readers the newest research as well as oncology-related news and http://healingmagic.net/2017/01/04/mikhail-blagosklonnys-plans-for-oncology/.